SONG JIN KIM: Open Payments
NPI 1336380203 · CENTREVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 59 payments from 11 companies in 2025. Trend: 2023 $28 · 2024 $1,728 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $392 |
| Regeneron Healthcare Solutions, Inc. | 9 | $180 |
| Lilly USA, LLC | 8 | $170 |
| Janssen Biotech, Inc. | 4 | $132 |
| Incyte Corporation | 4 | $111 |
| Amgen Inc. | 3 | $83 |
| UCB, Inc. | 2 | $63 |
| Organon LLC | 2 | $51 |
| PFIZER INC. | 2 | $51 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
Products named: RINVOQ, DUPIXENT, SKYRIZI, TREMFYA, TALTZ, OPZELURA, OTEZLA, Bimzelx.
Industry payments across VA — which companies pay providers there.
